LPL Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
569,234
-53,838
-9% -$172K ﹤0.01% 3513
2025
Q4
$1.7M Buy
623,072
+11,675
+2% +$27K ﹤0.01% 3548
2025
Q3
$1.33M Buy
611,397
+127,070
+26% +$300K ﹤0.01% 3727
2025
Q2
$833K Buy
484,327
+107,931
+29% +$269K ﹤0.01% 3914
2025
Q1
$1.25M Buy
376,396
+125,689
+50% +$648K ﹤0.01% 3360
2024
Q4
$1.86M Buy
250,707
+16,252
+7% +$151K ﹤0.01% 2928
2024
Q3
$2.2M Sell
234,455
-9,384
-4% -$88.9K ﹤0.01% 2632
2024
Q2
$1.96M Buy
243,839
+3,162
+1% +$33.9K ﹤0.01% 2622
2024
Q1
$3.57M Buy
240,677
+111,541
+86% +$1.3M ﹤0.01% 2048
2023
Q4
$1.05M Buy
129,136
+25,592
+25% +$134K ﹤0.01% 3006
2023
Q3
$471K Buy
103,544
+29,108
+39% +$190K ﹤0.01% 3540
2023
Q2
$524K Buy
74,436
+5,667
+8% +$40.6K ﹤0.01% 3406
2023
Q1
$420K Buy
68,769
+7,950
+13% +$54.9K ﹤0.01% 3477
2022
Q4
$389K Buy
60,819
+13,999
+30% +$109K ﹤0.01% 3466
2022
Q3
$449K Sell
46,820
-1,194
-2% -$13.8K ﹤0.01% 3248
2022
Q2
$530K Buy
48,014
+23,018
+92% +$302K ﹤0.01% 3147
2022
Q1
$416K Buy
24,996
+5,929
+31% +$91.7K ﹤0.01% 3334
2021
Q4
$364K Buy
19,067
+958
+5% +$21.1K ﹤0.01% 3548
2021
Q3
$447K Buy
18,109
+1,865
+11% +$43.9K ﹤0.01% 3320
2021
Q2
$423K Buy
+16,244
New +$422K ﹤0.01% 3295
2021
Q1
Sell
-5,465
Closed -$254K 4119
2020
Q4
$254K Sell
5,465
-1,404
-20% -$55.7K ﹤0.01% 3342
2020
Q3
$226K Buy
+6,869
New +$211K ﹤0.01% 3113
2019
Q4
Sell
-25,097
Closed -$457K 3372
2019
Q3
$457K Buy
+25,097
New +$555K ﹤0.01% 2325

Other funds holding IOVA